Iomeron (Iomeprol)

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as an injectable solution for intraarterial, intrathecal and intravenous use. It enhances X‑ray attenuation, allowing clearer visualization of vascular and tissue structures during imaging procedures. Iomeron is employed primarily in diagnostic radiology to improve image quality for patients undergoing contrast‑enhanced studies.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iomeron is used in radiographic imaging procedures that require enhanced contrast of vascular and tissue structures.

- Angiography: provides high‑contrast visualization of blood vessels during X‑ray examinations. - Myelography: improves delineation of the spinal canal and nerve roots for diagnostic evaluation. - Computed tomography (CT) imaging: increases tissue differentiation, facilitating accurate diagnosis in contrast‑enhanced CT scans.

Iomeron may cause a range of adverse reactions, from mild to severe, depending on patient sensitivity and clinical context.

Common Side Effects: - Warm sensation or flushing at the injection site. - Nausea or mild vomiting. - Transient headache or dizziness. - Mild hypotension or feeling of light‑headedness. - Metallic taste in the mouth. - Mild injection‑site discomfort.

Serious or Rare Side Effects: - Severe allergic reaction or anaphylaxis. - Acute renal toxicity, especially in patients with pre‑existing kidney impairment. - Persistent hypotension or cardiovascular collapse. - Cardiac arrhythmias. - Seizures or neurologic disturbances. - Life‑threatening bronchospasm.

Prior to administration, clinicians should evaluate patient-specific risk factors and follow appropriate safety measures.

- Renal function assessment: verify adequate kidney function before use. - Allergy history: screen for prior reactions to iodinated contrast agents. - Thyroid disease: consider potential iodine load in patients with hyper‑ or hypothyroidism. - Hydration status: ensure adequate hydration to reduce nephrotoxic risk. - Pregnancy considerations: use only if clearly needed, as safety data are limited. - Store at ambient temperature: keep in original container, protect from moisture and direct light.

Iomeron can interact with other medications, influencing safety or efficacy.

Major Interactions (Avoid): - Concurrent use of other iodinated contrast agents: increases total iodine load and risk of toxicity. - High‑dose nephrotoxic drugs (e.g., aminoglycosides, amphotericin B): may exacerbate renal impairment.

Moderate Interactions (Monitor Closely): - Diuretics: may affect fluid balance and renal clearance. - Metformin: monitor for lactic acidosis in patients with reduced kidney function. - Beta‑blockers or ACE inhibitors: may influence blood pressure response during contrast administration.